To investigate the effect of excess genistein on the extracellular matrix in mandibular condylar cartilage of female rats in vivo. Methods: Female SD rats were administered through oral gavage with genistein (50 mg/kg) or placebo daily for 6 weeks. The morphological changes of temporomandibular joints were studied with HE staining. The expression of cartilage matrix compounds (aggrecan and collagen type II), estrogen-related molecules (aromatase, estradiol, ERα and ERβ) and proliferating cell nuclear antigen (PCNA) in mandibular condylar cartilage was detected using immunohistochemistry, ELISA and real-time PCR. Results: The genistein treatment significantly reduced the thickness of the posterior and middle regions of mandibular condylar cartilage, and decreased the expression of collagen type II, aggrecan and PCNA. Compared with the control group, the estradiol content and expression levels of the key estradiol-synthesizing enzyme aromatase in the genistein-treatment group were significantly decreased. The genistein treatment significantly increased the expression of ERβ, but decreased the expression of ERα. Conclusion: Excess genistein suppresses extracellular matrix synthesis and chondrocytes proliferation, resulting in thinner mandibular condylar cartilage. These effects may be detrimental to the ability of mandibular condylar cartilage to adapt to mechanical loads.
Introduction
Osteoarthritis (OA) is the most common arthropathy in elderly people, and its socio-economic impact has increased as life expectancy has risen. OA is a degenerative disease characterized by the loss of collagens and proteoglycans as the main structural molecules of articular cartilage [1] . Epidemiological studies have shown that the prevalence and incidence of OA increase after menopause and that OA symptoms are more severe in postmenopausal women than in men [2] [3] [4] , which suggests a link between OA and estrogen.
Although estrogen replacement therapy (ERT) has been proven to reduce the risk of OA [5] [6] [7] , its application is hampered by an increased risk of breast cancer, myocardial infarction, and stroke [8, 9] . Therefore, using phytoestrogens, which lack the specific side-effects of estrogens, may provide an alternative therapy [10, 11] . Phytoestrogens are abundant in soybean products [12] ; genistein, which structurally resembles # These authors contributed equally to this work. * To whom correspondence should be addressed.
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17β-estradiol, is particularly abundant. It has been shown that genistein can bind to estrogen receptors (ERs) with an affinity 100 to 1000-fold less than that of estradiol and that it competes with estradiol and displaces it from its binding sites [13] . A clinical study has suggested that consuming 88 mg phytoestrogen per day may benefit OA patients [14] . Hooshmand et al have also reported that genistein reduced the in vitro production of lipopolysaccharide-induced cyclooxygenase (COX)-2 in chondrocytes, indicating that genistein may be an attractive and viable alternative therapy for treating or preventing OA [15] . The temporomandibular joint (TMJ) plays an important role in craniofacial growth and function and shows a high incidence of OA [16] . In the literature, estrogen has been shown to play an important role in the development of TMJ and temporomandibular diseases [17] [18] [19] . These findings have been supported by the existence of estrogen receptors (ERs) in mandibular condylar cartilage [20, 21] . As an estrogen-targeted tissue [20, 21] , cartilage is usually a solid connective tissue that covers subchondral bone tissue and plays an important role in the development of OA. To the best of our knowledge, however, few studies of the effect of genistein on cartilage have been reported, especially in vivo studies. The 
Materials and methods

Genistein treatment in vivo
All the animal experimental procedures were approved by the Animal Research Committee of the Fourth Military Medical University. Thirty 7-week-old female SD rats, weighing 180-190 g, were provided by the animal center of the Fourth Military Medical University. All animals were housed at 22°C and 30%-60% relative humidity with a normal daynight rhythm (a 12:12 h light-dark cycle). The animals were randomly assigned to vehicle control and genistein-treatment groups (15 in each group). They had free access to tap water and a phytoestrogen-free diet in which corn oil was replaced with soybean oil. In the literature, the bone-protective effects of genistein (3-54 mg·kg
) have been reported in OVX rats, mice and postmenopausal women [22] . There have been few studies focusing on the effect of genistein on normal or intact animals. Based on a series of genistein safety studies, the no observed adverse effect level (NOAEL) for genistein in rats has been estimated to be 50 or 100 mg·kg -1 ·d -1 [13, 23] . Consistent with our previous study [22] , 50 mg·kg -1 ·d -1 genistein was chosen as excess dose in the present study. The animals were treated once daily with genistein (50 mg/kg body weight, 99.5% pure, Winherb Medical Science Co Ltd, China) or placebo by oral gavage. The genistein was dissolved in a placebo solution (0.9% NaCl, 2% Tween 80, and 0.5% methyl cellulose in water). The application volume was 5 mL/kg body weight. Changes in body weight during the experimental period were considered when calculating the genistein dosage. All the animals were sacrificed 6 weeks after the initiation of treatment.
Tissue preparation
For the morphological and immunohistochemistry analyses 10 rats (5 from each group) received deep anesthesia from an intraperitoneal injection of pentobarbital sodium (50 mg/kg body weight) and were perfused with 200 mL of normal saline and 400 mL of paraformaldehyde (4% in phosphate buffer saline, pH 7.4) through their ascending aortas. The TMJs and the uterus were harvested without fatty tissue. The wet weight of uterus was measured by electron precision balance. A uterine weight index was used to measure the changes in the uterus [uterine weight index=WW (mg)/BW (g), where WW=wet weight and BW=body weight] [9] . The TMJs were post-fixed overnight at 4 °C with the same fixative and decalcified for 1 week in Kristensen′s fluid (sodium formate 52.2 g, formic acid 174.2 mL, and 1000 mL distilled water). The TMJ samples were then dehydrated in graded ethanol and embedded in paraffin. Serial 5-µm mid-sagittal sections were cut parallel to the lateral surface of the condyle. To ensure a reliable comparison between the vehicle control and experimental groups, mid-sagittal sections from each joint were chosen for the morphological and immunohistochemistry analyses.
The other six rats in each group were sacrificed for the realtime PCR analysis. To obtain enough total RNA, four sets of condylar cartilages from 2 randomly selected rats constituted one sample; hence, 12 sets of condylar cartilages from 6 rats in each group were randomly assigned to 3 samples.
Histological analysis
The hematoxylin and eosin (HE) stained sections were examined under a light microscope (Leica DM2500, Wetzlar, Germany). A true-color computer-assisted image analyzing system with a digital camera (Leica DFC420, Leica, Wetzlar, Germany) and software (Qwin Plus, Leica Microsystem Imaging Solutions Ltd, Cambridge, United Kingdom) were used for image capture and measurement. The thickness of the condylar cartilage was measured in each section. The condylar cartilage was divided approximately into anterior, middle and posterior regions. In every region, the thickness was measured at three quartering points. The means of the three measurements were used for the statistical analysis.
Immunohistochemical staining and analysis
Five commercially available primary antibodies were used for the immunohistochemical staining: anti-human collagen type II goat polyclonal IgG (SC7763, Santa Cruz Biol Inc, USA); anti-rat proliferating cell nuclear antigen (PCNA) mouse monoclonal IgG (MS-106, Labvision Ltd, USA); anti-human aromatase rabbit polyclonal IgG (AB69653, Abcam, UK); antihuman ERα rabbit polyclonal IgG (SC542, Santa Cruz Biol Inc, USA); and anti-human ERβ rabbit polyclonal IgG (SC8974, Santa Cruz Biol Inc, USA). The immunohistochemical staining was conducted using a three-step avidin-biotin complex method that has been previously described [24] . The sections were incubated overnight at 4 °C with anti-human collagen type II goat polyclonal IgG (3 µg/mL), anti-rat PCNA mouse monoclonal IgG (3 µg/mL), anti-human aromatase rabbit polyclonal IgG (10 µg/mL), anti-human ERα rabbit polyclonal IgG (4 µg/mL), and anti-human ERβ rabbit polyclonal IgG (3 µg/mL).
The immunohistochemical staining for aromatase, ERα, ERβ, and PCNA was analyzed by the Qwin Plus software. Briefly, the stained sections were observed under a Leica DM2500 light microscope with a ×10 objective. The measurements were performed in middle and posterior regions of the condylar cartilage, where they regularly appeared among the animals. For the aromatase, ERα and ERβ analyses, the measurement area consisted of the complete mature and hypertrophic layers in which immunoreactive signals were obvious. The positively stained region and the complete selected region covering the mature and hypertrophic layers, respectively, were measured. The percentage of the entire region that stained positive was calculated. For the PCNA sections, 4 cubic regions (300 pixels×300 pixels) were selected from approximately the middle and posterior regions of the condylar cartilage. The number of PCNA-positive chondrocytes was determined. Finally, the percent of the region that stained positive and the sum of the PCNA-positive cells in all of the cartilage were used for the statistical analysis. Table 1 shows the sequences of primers used in this study. All the PCRs were run in triplicate for each sample, and the threshold cycles (CT) were measured. A ∆CT value was calculated for each sample by subtracting the CT value of the reference gene (18S) from the CT value of the gene of interest. 18S has been used as internal standard in several studies. All the samples were normalized to the ∆CT value of a control sample (∆∆CT). The relative expression of the target gene was calculated using the expression 2 -∆∆CT and is reported in arbitrary units [25] .
Enzyme-linked immunosorbent assay (ELISA) for determination of estradiol
For the ELISA analysis, the remaining 8 rats (4 from each group) were sacrificed under deep anesthesia. Two mandibular condylar cartilage sections from the same rat were used a single sample, giving 4 samples from each group. 
Results
Excess genistein increased the uterus weight index
The uterus weight index of the genistein-treatment group (2.2714±0.18875) increased significantly (P<0.01) compared to the control group (1.7884±0.11068).
Excess genistein suppressed the synthesis of extracellular matrix
In the mandibular condylar cartilage of both the control and genistein-treatment groups, the fibrous, proliferating, mature and hypertrophic layers were regularly arranged and had good continuity within the layers ( Figure 1A and 1B) . The thickness of the posterior and middle regions of the condylar cartilage in genistein-treated group decreased significantly (P<0.01) compared to the control group, however ( Figure  1C ). Consistent with the decreased cartilage thickness, the Excess genistein suppressed the proliferation of chondrocytes As shown in Figure 3 , the density of PCNA-positive chondrocytes was lower in the genistein-treatment group (90.4±12.7) than in the control group (217.6±28.1) (P<0.01).
Excess genistein decreased the level of estradiol in condylar cartilage
The ELISA results showed that the estradiol content was lower in the genistein-treatment group (2.1310±0.20756 ng) than in the vehicle control group (3.4293±0.23953 ng) (P<0.01). Additionally, the expression of the key estradiol-synthesizing enzyme aromatase (as measured by both protein and mRNA levels) was lower in the genistein-treatment group (P<0.01) (Figure 4 ) than in the control group.
Excess genistein decreased the expression of ERα, but increased that of ERβ As for the ER expression, the ERα mRNA levels and immunohistochemical signals were lower in the genistein-treatment group than in the control group (P<0.01). However, both the mRNA levels and immunohistochemical signals for ERβ were significantly higher in the genistein-treatment group than in the control group (P<0.01) (Figure 4, 5) .
Discussion
To the best of our knowledge, our study is the first to investigate the effects of genistein on mandibular condylar cartilage. Although the effect of phytoestrogens, especially genistein, on the extracellular cartilage matrix has been discussed in the literature, the data are not consistent. An in vitro study found that articular chondrocyte glycosaminoglycans (GAG) synthesis was significantly diminished following incubation with high doses of genistein (10 -5 -10 -4 mol/L) but that the level of sulfate npg incorporation was not affected [1] . Nevertheless, Hooshmand et al found that high doses of genistein (10 -5 -10 -4 mol/L) could suppress the increased levels of YKL-40 (a marker of cartilage glycoprotein degradation) in chondrocyte supernatant that is induced by LPS treatment [15] . One preclinical study found that long-term soy phytoestrogen treatment (129 mg/day/person) did not have a statistically significant effect on the levels of collagen or proteoglycan in articular cartilage [26] . Our results showed that compared with the control group, both the expression of the main components of the extracellular matrix cartilage (collagen type II and aggrecan) and chondrocyte proliferation decreased significantly in genistein-treatment group, resulting in thinner mandibular condylar cartilage in the posterior and middle regions. This result is consistent with a previous report that additional estradiol (10 -8 mol/L) can decrease extracellular matrix synthesis, chondrocyte proliferation and the thickness of mandibular condylar cartilage in vitro [19] . Maintaining articular cartilage throughout the life of an organism plays a crucial role in establishing the biological range of cartilage adaptability [19] . Modulating cartilage thickness and extracellular matrix properties using excess genistein may create an environment more susceptible to degenerative changes.
It has been shown that chondrocytes in mandibular cartilage can locally synthesize estradiol through the activity of aromatase [24] . In the present study, both the aromatase expression and estradiol content of mandibular condylar cartilage decreased significantly after the genistein treatment, while the uterus index increased. It is possible that a particular dose of genistein can exert an estrogenic effect in cartilage by competing with local estrogen, although its effect is weak. Therefore, the need for autocrine estrogen in cartilage metabolism decreases when genistein exerts its estrogen-like activity [13] . The literature has suggested that genistein may be completely agonistic to both ERα and ERβ, although it is more potent for ERβ than ERα [27, 28] . It has been shown that the binding affinity of genistein was seven times greater for ERβ than for ERα [29] . A recent study found that the increased ERβ expression in the genioglossus muscle after genistein treatment was much higher than that of ERα [9] . Our previous study also demonstrated that the effect of genistein on mandibular subchondral bone was predominantly mediated through ERβ [22] . The present study showed that ERβ expression increased significantly following treatment with excess genistein, while ERα expression decreased at both the protein and mRNA levels. These results may indicate that genistein exerts its estrogenic activity in mandibular condylar cartilage mainly through ERβ, which is consistent with another recent finding that the effects of genistein on skeletal muscle major histocompatibility complex (MHC) expression was predominantly mediated through ERβ [30] . In summary, the present study demonstrated that excess genistein can suppress extracellular matrix synthesis and chondrocyte proliferation in rat mandibular condylar cartilage, resulting in thinner mandibular condylar cartilage. This finding may imply decreased adaptivity to mechanical loads in mandibular condylar cartilage. Given the fluctuating differences in estrogen levels between individuals, the proper genistein dose should be studied further if genistein is to be widely used to treat OA or osteoporosis.
